Rockefeller Capital Management’s Mereo BioPharma MREO Stock Holding History

Rockefeller Capital Management’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$660	Hold	2,000	–	–	﹤0.01%	4539
2025 Q4	$833	Hold	2,000	–	–	﹤0.01%	4475
2025 Q3	$4.12K	Buy	+2,000	New	+$3.69K	﹤0.01%	3930
2023 Q1	–	Sell	-358	Closed	–	–	3162
2022 Q4	$0	Hold	358	–	–	﹤0.01%	4079
2022 Q3	$0	Hold	358	–	–	﹤0.01%	4196
2022 Q2	$0	Hold	358	–	–	﹤0.01%	4288
2022 Q1	$0	Hold	358	–	–	﹤0.01%	3997
2021 Q4	$0	Hold	358	–	–	﹤0.01%	3909
2021 Q3	$0	Hold	358	–	–	﹤0.01%	3790
2021 Q2	$1K	Hold	358	–	–	﹤0.01%	3355
2021 Q1	$1K	Hold	358	–	–	﹤0.01%	3189
2020 Q4	$1K	Hold	358	–	–	﹤0.01%	2751
2020 Q3	$0	Hold	358	–	–	﹤0.01%	2705
2020 Q2	$1K	Hold	358	–	–	﹤0.01%	2467
2020 Q1	$0	Hold	358	–	–	﹤0.01%	2433
2019 Q4	$1K	Hold	358	–	–	﹤0.01%	1993
2019 Q3	$1K	Buy	+358	New	+$1.08K	﹤0.01%	1865

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $712M AUM

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Rockefeller Capital Management's MREO Position: Q1 2026 in Review

Rockefeller Capital Management held its Mereo BioPharma (MREO) position steady in Q1 2026 at 2,000 shares worth $660. The position accounts for ﹤0.01% of the portfolio, ranked #4539.

Rockefeller Capital Management first reported a position in MREO in Q3 2019 and has held it in 17 quarters since. The position peaked at $4.12K in Q3 2025. 63 funds tracked by Wall St. Rank hold MREO as of Q1 2026.

Rockefeller Capital Management held 2,000 shares of Mereo BioPharma worth $660 as of Q1 2026.
Rockefeller Capital Management left its Mereo BioPharma share count unchanged in Q1 2026.
Mereo BioPharma made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4539 holding.
Rockefeller Capital Management first reported a position in Mereo BioPharma in Q3 2019 and has held it in 17 quarters since.
Rockefeller Capital Management's Mereo BioPharma position peaked at $4.12K in Q3 2025.
63 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.